PRKAG2 variants in HCM cohorts


The table below lists the 42 rare (MAF<0.0001 in ExAC) protein-altering PRKAG2 variants identified in a cohort of 3973 HCM patients (1535 patients from OMGL, 2438 patients from LMM). When this rare variant frequency of 0.01057 is compared with a background population rate of 0.00532, there is a statistically significant case excess of 0.00525 (p=0.0001), which suggests that approximately 21 of these variants may be pathogenic.


Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      Combined (OMGL + LMM)     -     OMGL     -     LMM



No. Variant (CDS) Variant (Protein) Variant Type Cases (3973)OMGL classLMM class ExAC frequency
1. c.905G>A p.R302Qmissense 5Pathogenic (2)Pathogenic (3)0.000000
2. c.1647C>G p.D549Emissense 1VUS (1)0.000000
3. c.425C>T p.T142Imissense 1VUS (1)0.000074
4. c.1006G>A p.V336Imissense 1VUS (1)0.000000
5. c.989A>G p.Y330Cmissense 1VUS (1)0.000000
6. c.431C>T p.P144Lmissense 2VUS (2)0.000024
7. c.1315A>G p.I439Vmissense 1VUS (1)0.000024
8. c.1436T>C p.I479Tmissense 1VUS (1)0.000000
9. c.1475T>A p.I492Nmissense 1VUS (1)0.000032
10. c.1592G>T p.R531Lmissense 1VUS favour pathogenic (1)0.000000
11. c.488C>T p.P163Lmissense 1VUS (1)0.000000
12. c.1516G>C p.E506Qmissense 1Likely Pathogenic (1)0.000000
13. c.865G>A p.V289Imissense 1VUS (1)0.000008
14. c.1518A>C p.E506Dmissense 1VUS (1)0.000000
15. c.1508A>G p.Q503Rmissense 1VUS (1)0.000016
16. c.1703C>T p.T568Mmissense 1VUS (1)0.000098
17. c.608G>A p.R203Kmissense 1VUS (1)0.000000
18. c.1592G>A p.R531Qmissense 5Pathogenic (1)Pathogenic (4)0.000000
19. c.186G>T p.K62Nmissense 1VUS (1)0.000000
20. c.722G>A p.G241Dmissense 1VUS (1)0.000000
21. c.532G>A p.E178Kmissense 1VUS (1)0.000000
22. c.1066G>A p.E356Kmissense 1VUS (1)0.000000
23. c.428C>T p.S143Lmissense 1VUS (1)0.000008
24. c.1267C>A p.Q423Kmissense 2VUS (1)VUS (1)0.000032
25. c.1648A>C p.I550Lmissense 1VUS (1)0.000032
26. c.47G>C p.S16Tmissense 1VUS (1)0.000000
27. c.1030C>T p.H344Ymissense 1Likely Pathogenic (1)0.000000
28. c.1459T>G p.Y487Dmissense 1VUS (1)0.000000
29. c.166G>A p.G56Rmissense 1VUS (1)0.000052
30. c.563A>G p.E188Gmissense 1VUS (1)0.000000
31. c.1687C>T p.Q563Xnonsense 1VUS (1)0.000008
32. c.593_594insC p.Asp199fsframeshift 1VUS (1)0.000000

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.

2. Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med. 2015 Nov;17(11):880-8.